![]() |
市場調査レポート
商品コード
1800791
プレパッククロマトグラフィーカラムの市場レポート:タイプ別、技術別、用途別、最終用途別、地域別、2025~2033年Prepacked Chromatography Columns Market Report by Type, Technique, Application, End-Use, and Region 2025-2033 |
||||||
カスタマイズ可能
|
プレパッククロマトグラフィーカラムの市場レポート:タイプ別、技術別、用途別、最終用途別、地域別、2025~2033年 |
出版日: 2025年08月01日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2~3営業日
|
世界のプレパッククロマトグラフィーカラムの市場規模は2024年に22億米ドルに達しました。今後、IMARC Groupは、市場は2033年までに39億米ドルに達し、2025~2033年の成長率(CAGR)は6.3%になると予測しています。さまざまな慢性疾患の有病率の増加、疾病管理用のバイオ医薬品需要の高まり、さまざまな産業におけるクロマトグラフィーの利用拡大などが、市場の成長を後押しする主な要因の1つです。
バイオ医薬品に対する需要の増加
がん、糖尿病、心血管疾患、自己免疫疾患など、さまざまな慢性疾患の有病率の上昇が市場の成長を促進しています。このことは、疾病管理のためのバイオ医薬品に対する需要の高まりと相まって、市場の成長を強化しています。NIHによると、2022年のインドにおけるがんの推定罹患数は14,61,427人(粗率 100.4/100,000)です。小児(0~14歳)のがんのうち、リンパ性白血病(男児 29.2%、女児 24.2%)が主要部位でした。がん罹患率は、2020年と比較して2025年には12.8%増加すると推定されています。例えば、IDF糖尿病アトラス(2021年)によると、成人人口(20~79歳)の10.5%が糖尿病を患っており、半数近くが糖尿病を患っていることに気づいていません。IDFの予測では、2045年までに成人の8人に1人、約7億8,300万人が糖尿病を患うことになり、その割合は46%増加します。これはプレパッククロマトグラフィーカラム市場の統計に大きな影響を与えます。
クロマトグラフィーの著しい技術進歩
クロマトグラフィー技術の継続的な進歩も市場を牽引しています。例えば、高速液体クロマトグラフィー(HPLC)やアフィニティークロマトグラフィーを含むクロマトグラフィー技術における継続的な技術革新により、分離の効率、速度、分離能が向上しています。環境検査におけるクロマトグラフィの普及は、市場の成長に影響を与えています。例えば、2023年6月、Agilent Technologies Inc.は、2つの新しい液体クロマトグラフ質量分析システム(LCMS)、Agilent 6495D LC/TQとAgilent Revident LC/Q-TQFを発表しました。Agilentは、Revident LC/Q-TQFのハイエンド性能を促進するために、新しいAgilent MassHunter Explorerプロファイリングソフトウェアと新しいAgilent ChemVistraライブラリマネージャソフトウェアも発表しました。これにより、今後数年間のプレパッククロマトグラフィーカラム市場予測に弾みがつくことが期待されます。
バイオプロセスとシングルユーステクノロジーへの注目の高まり
バイオ医薬品およびバイオテクノロジー業界では、生産を合理化し交差汚染のリスクを低減するためにシングルユース技術への注目が高まっており、これが市場の成長に寄与しています。シングルユースのプレパックカラムは、バッチ間の洗浄やバリデーション工程を不要にすることで、貴重な生産時間の利用を最適化し、より効率的でコスト効率の高い製造につながります。例えば、2023年9月、バイオプロセス技術のリーダーシップに焦点を当てたライフサイエンス企業であるRepligen Corporationは、スウェーデンMolndalの非公開企業Metenova AB(Metenova)を買収する正式契約を締結したと発表しました。Metenovaは、世界のバイオ医薬品企業や開発・製造受託機関(CDMO)で広く使用されている磁気ミキシング技術やドライブトレイン技術の成功に牽引され、2023年度には2,400万~2,500万米ドルの収益が見込まれています。同社は最近、既存のステンレス製(繰り返し使用)製品ラインの成功を活用し、MixOneプラットフォームを発表してシングルユースミキシング市場に参入しました。
The global prepacked chromatography columns market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2033, exhibiting a growth rate (CAGR) of 6.3% during 2025-2033. The growing prevalence of various chronic diseases, the rising demand for biopharmaceuticals for disease management, and increasing utilization of chromatography across various industries are some of the major factors propelling the growth of the market.
Increased Demand for Biopharmaceuticals
The rising prevalence of various chronic diseases including cancer, diabetes, cardiovascular disorders, and autoimmune conditions is driving the growth of the market. This, coupled with the escalating demand for biopharmaceuticals for disease management is strengthening the growth of the market. According to NIH, the estimated number of incident cases of cancer in India for the year 2022 was found to be 14,61,427 (crude rate:100.4 per 100000). Among the childhood (0-14 yr) cancers, lymphoid leukemia (boys: 29.2% and girls: 24.2%) was the leading site. The incidence of cancer cases is estimated to increase by 12.8% in 2025 as compared to 2020. For instance, IDF Diabetes Atlas (2021) reports that 10.5% of the adult population (20-79 years) has diabetes, with almost half unaware that they are living with the condition. By 2045, IDF projections show that one in eight adults approximately 783 million, will be living with diabetes an increase of 46%. This is infleuncing the prepacked chromatography columns market statistics significantly.
Significant Technological Advancement in Chromatography
The market is also driven by continuous advancements in chromatography technology. For instance, ongoing innovations in chromatographic techniques including high-performance liquid chromatography (HPLC) and affinity chromatography are improving the efficiency, speed, and resolution of separation. The widespread adoption of chromatography in environmental testing is influencing the growth of the market. For instance, in June 2023, Agilent Technologies Inc. announced two new liquid chromatography-mass spectrometry systems (LCMS), the Agilent 6495D LC/TQ and the Agilent Revident LC/Q-TQF. Facilitating the high-end performance of the Revident LC/Q-TQF, Agilent is also announcing the new Agilent MassHunter Explorer Profiling software and the new Agilent ChemVistra library manager software. This is expected to fuel the prepacked chromatography columns market forecast over the coming years.
Rising Emphasis on Bioprocessing and Single-Use Technologies
The increasing focus of biopharmaceutical and biotechnology industries towards single-use technologies to streamline production and reduce cross-contamination risk is contributing to the growth of the market. Single-use prepackaged columns optimize the use of valuable production time by eliminating the need for cleaning and validation steps between batches which leads to more efficient and cost-effective manufacturing. For instance, in September 2023, Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it has entered into a definitive agreement to acquire privately held Metenova AB (Metenova) of Molndal, Sweden. Metenova is projected to generate revenues of $24 million to $25 million for fiscal year 2023, led by the success of its magnetic mixing and drive train technologies that are widely used by global biopharmaceutical companies and contract development and manufacturing organizations (CDMOs). The company recently entered the single-use mixing market with the launch of its MixOne platform, leveraging the success of its existing stainless steel (repeat-use) product line.
>1000 ML accounts for the majority of the market share
The rising preference for large column sizes across different industry verticals is driving the market segment. >1000 ML prepacked columns are commonly employed for the purification of biomolecules such as monoclonal antibodies, proteins, and vaccines. They facilitate high-capacity chromatographic separations, ensuring the production of pure and high-quality biopharmaceutical products. Additionally, food and beverage (F&B) manufacturers utilize >1000 mL prepacked columns for tasks like flavor extraction, quality control, and the separation of components like sugars, amino acids, and colorants. These columns aid in achieving consistent product quality and compliance with food safety regulations. In chemical research and development (R&D), these columns are essential for synthesizing and purifying compounds. Researchers can scale up their chromatographic processes efficiently, saving time and resources while ensuring product purity.
Ion-exchange chromatography holds the majority of the market share
Ion-exchange chromatography is versatile and can be applied to a wide range of biomolecules, including proteins, nucleic acids, and other charged molecules. This adaptability makes it suitable for various research and industrial applications. Additionally, it offers excellent selectivity based on the charge of the molecules being separated. By using ion-exchange resins with different functional groups, researchers can effectively separate and purify target molecules from complex mixtures. Apart from this, it provides high-resolution separation, enabling the isolation of closely related species with different charge properties. Furthermore, it can be easily scaled up for industrial production, making it suitable for large-scale purification processes in biopharmaceuticals, food processing, and other industries.
Sample preparation represents the largest market segment
Sample preparation is a fundamental prerequisite for chromatographic analyses which is fueling the segment growth in the market. It involves the extraction, clean-up, and concentration of target molecules from complex samples, ensuring that only relevant compounds reach the chromatography columns. The quality of sample preparation directly influences the accuracy and sensitivity of subsequent chromatographic analyses, making it an essential step. Additionally, diverse industries, including pharmaceuticals, biotechnology, food and beverage, environmental monitoring, and healthcare, heavily rely on chromatography for quality control, research, and product development. Furthermore, ongoing advancements in analytical techniques, such as high-performance liquid chromatography (HPLC) and mass spectrometry (MS), demand sample preparation methods that can cater to evolving needs.
Pharmaceutical and biotechnology companies account for the largest market share
Pharmaceutical and biotechnology companies are subject to rigorous regulatory requirements to ensure the safety and efficacy of their products which is further driving the segment growth in the market. Chromatography is a trusted and standardized method for characterizing and purifying compounds, making prepacked columns an attractive option for achieving compliance and maintaining consistency in manufacturing. Moreover, the continuous advancements in biopharmaceuticals, including monoclonal antibodies and gene therapies, have led to increased demand for specialized chromatography columns tailored to these complex molecules. Furthermore, these industries rely on precise and efficient separation and purification of biomolecules, such as proteins, antibodies, and nucleic acids, at various stages of drug development, production, and quality control. Prepacked chromatography columns offer ready-to-use solutions that significantly streamline these processes, reducing time and labor costs.
North America leads the market, accounting for the largest prepacked chromatography columns market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for prepacked chromatography columns.
North America is home to numerous pharmaceutical and biotechnology companies engaged in drug discovery, development, and production which is driving the market growth. Additionally, pharmaceutical and biotechnology sectors in North America are subject to strict regulatory standards set by the U.S. Food and Drug Administration (FDA) and Health Canada. Apart from this, several major players in the chromatography column manufacturing industry are headquartered or have a significant presence in North America. This concentration of key industry players fosters competition, innovation, and a wide range of product offerings. Furthermore, the region boasts advanced healthcare infrastructure, including cutting-edge diagnostic laboratories and healthcare facilities. Chromatography is extensively used in clinical diagnostics and research, further fueling the demand for prepacked columns. For instance, in February 2024, Shimadzu Corporation acquired the catalytic micro-reactive business for gas chromatography (GC) from Activated Research Company, LLC (ARC, Minnesota, USA).
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)